<- Back to digest

JHS - 2026-11-13 - Journal Article

Expanding the Role of MRI Neurography in the Diagnosis of Neurogenic Thoracic Outlet Syndrome.

Cervantes Valadez S, De la Fuente Hagopian A, Hoffpauir LA, Trakhtenbroit M, Echo A

retrospective cohortLOE IIIn = 32N/A

Topics

handspineshoulder elbow
PMID: 43023963DOI: 10.1016/j.jhsa.2026.09.003View on PubMed ->

Key Takeaway

MRI neurography detected neurogenic TOS in 78.1% of surgical candidates versus 43.8% for EMG, supporting its integration into the diagnostic workup.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This retrospective study evaluated MRN's diagnostic yield in 32 patients who underwent TOS release (with or without first rib resection) between 2021 and 2024, comparing it to EMG and conventional MRI. MRN identified nTOS in 25/32 patients (78.1%) versus EMG in 14/32 (43.8%), with the 7 MRN-negative patients also negative on EMG and conventional MRI. Postoperatively, 29/32 patients reported meaningful improvement or complete resolution of symptoms.

Key Limitation

The absence of a non-surgical nTOS cohort or asymptomatic controls means the specificity of MRN findings such as nerve hyperintensity and thickening for nTOS remains unknown, limiting its standalone diagnostic value.

Original Abstract

PURPOSE

Neurogenic thoracic outlet syndrome (nTOS) is characterized by compression of neurovascular structures in the neck and shoulder region, leading to pain and paresthesias in the upper extremity. Diagnosis has traditionally been one of exclusion and heavily reliant on the clinical acumen of the physician. As magnetic resonance imaging (MRI) neurography (MRN) has become more readily available, it could help with the identification of patients with nTOS. This study evaluates MRN's reliability in aiding the diagnosis of nTOS.

METHODS

We conducted a retrospective study of 32 patients who underwent TOS release surgery, with or without first rib resection, between 2021 and 2024. Patient records were reviewed for clinical presentation, demographics, TOS etiology, and diagnostic evaluation. We assessed MRN's ability to diagnose TOS compared with other methods, such as electromyography (EMG) or conventional upper extremity MRI.

RESULTS

All 32 patients underwent MRN before surgery. TOS was identified by MRN in 25 of 32 (78.1%) and by EMG in 14 of 32 (43.8%). All patients had at least one positive objective sign during physical examination and subjective symptoms consistent with nTOS. The seven patients with a negative MRN were also negative by EMG and conventional MRI. After surgical decompression, 25 improved considerably compared with baseline, 4 achieved complete resolution, and 3 had persistent symptoms. The most common MRN findings were hyperintensity (80%), thickening (44%), and intramuscular edema of the supraspinatus and infraspinatus (16%). The most reported symptoms were pain, paresthesia and weakness. Additionally, 13 patients experienced symptom relief with injections.

CONCLUSIONS

MRN is a valuable diagnostic tool for nTOS, aiding in preoperative assessment and diagnosis. Its 78.1% detection rate supports its integration into a structured diagnostic algorithm alongside clinical evaluation. Further prospective studies are needed to validate its role as a standardized diagnostic modality for nTOS.

TYPE OF STUDY/LEVEL OF EVIDENCE

Diagnostic III.